China's Innovative Drug Exports Surge to $110B in H1 2026
Chinese innovative drug out-licensing deals hit $110 billion in H1 2026 as global pharma giants rush to license Chinese innovations.
Tag
6 articles
Chinese innovative drug out-licensing deals hit $110 billion in H1 2026 as global pharma giants rush to license Chinese innovations.
Chinese innovative drug out-licensing deals hit $110B in H1 2026 as global pharma giants partner with Chinese biotech firms for breakthrough therapies.
China's 'new new three items' - AI, robotics, and innovative drugs - are reshaping the nation's export identity from goods to capabilities.
China releases 2026 National Essential Drug List with 794 varieties, including innovative drugs for the first time in a landmark policy shift.
Xinhua calls for accelerated China innovative drug development as record BD deals top $100B and AI transforms R&D, but warns of weak basic research.
China's NHSA launches 2026 dual catalog adjustment for medical and commercial insurance, introducing pre-application mechanisms and expanded eligibility.